NCT05907993

Brief Summary

The aim of this study will be to evaluate the effectiveness of intravenous ibuprofen versus intravenous ketorolac for postoperative pain relief after caesarian section

  1. 1.The Primary outcome is measurement of visual analogue score during rest and movement
  2. 2.The Secondary outcome is measurement of 24 hours opioids requirements.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Feb 2023

Shorter than P25 for phase_4

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 18, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2023

Completed
Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

8 months

First QC Date

April 18, 2023

Last Update Submit

February 27, 2024

Conditions

Keywords

postoperativepain reliefCESAREAN SECTION

Outcome Measures

Primary Outcomes (1)

  • measurement of visual analogue score

    measurement of visual analogue score during rest and movement . The Score range from 0- 10 . 0 means no pain and 10 indicates the worst pain ever

    after the surgery average 24 hours postoperative

Secondary Outcomes (1)

  • opioids requirements.

    after the surgery average 24 hours postoperative

Study Arms (2)

Group (A):

NO INTERVENTION

30mg ketorolac in 200cc normal saline intravenously every 6hours for 24hours postoperatively.

Group (B):

ACTIVE COMPARATOR

800mg ibuprofen in 200cc normal saline intravenously every 6 hours for 24hours postoperatively.

Drug: Ibuprofen 800 mg

Interventions

Intravenous Ibuprofen versus intravenous Ketorolac for postoperative pain relief

Group (B):

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailspregnant Females
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Parturients aged 20-30years.
  • ASA physical satatus: II.
  • Anticipated hospital stay for at least 24 hours.
  • Refusal of spinal anaesthesia.

You may not qualify if:

  • Known allergy to the used drugs.
  • Renal and hepatic impairement
  • History of brochial asthma.
  • Low platelets count (\<70000).
  • Bleeding diathesis and with history or risk of intracranial hemorrhage.
  • Obese and morbidly obese parturients.
  • GIT problems as gastritis or GI bleeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed S. Shehab

Alexandria, 21431, Egypt

Location

Related Publications (1)

  • Ekinci M, Ciftci B, Celik EC, Kose EA, Karakaya MA, Ozdenkaya Y. A Randomized, Placebo-Controlled, Double-Blind Study that Evaluates Efficacy of Intravenous Ibuprofen and Acetaminophen for Postoperative Pain Treatment Following Laparoscopic Cholecystectomy Surgery. J Gastrointest Surg. 2020 Apr;24(4):780-785. doi: 10.1007/s11605-019-04220-1. Epub 2019 Apr 22.

    PMID: 31012040BACKGROUND

Related Links

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Ibuprofen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

PhenylpropionatesAcids, CarbocyclicCarboxylic AcidsOrganic Chemicals

Study Officials

  • Ahmed S. Shehab, MD

    Alexandria University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer Of Anaesthesia and Surgical intensive care

Study Record Dates

First Submitted

April 18, 2023

First Posted

June 18, 2023

Study Start

February 1, 2023

Primary Completion

September 30, 2023

Study Completion

October 30, 2023

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

17\. there is a plan to make individual participant data (IPD) collected in this study, including data dictionaries, available to other researchers

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
to the time when summary data are published
Access Criteria
Accessible through the web site

Locations